A proposed bill drawing bipartisan support in the Senate would establish a new pharmacy category, compounding manufacturers, that would have to register with the FDA and be overseen by the agency. The bill defines "compounding manufacturer" as a facility that generates sterile drugs and sells them across state lines in the absence of a prescription.

Full Story:

Related Summaries